356 related articles for article (PubMed ID: 27317567)
1. LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation.
Zhang P; Cao L; Fan P; Mei Y; Wu M
EMBO Rep; 2016 Aug; 17(8):1204-20. PubMed ID: 27317567
[TBL] [Abstract][Full Text] [Related]
2. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
3. MYC is a critical target of FBXW7.
Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
[TBL] [Abstract][Full Text] [Related]
5. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
6. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC.
Zhang Y; Peng Z; Zhao Y; Chen L
Med Sci Monit; 2016 Apr; 22():1415-20. PubMed ID: 27120728
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
Xu Y; Sengupta T; Kukreja L; Minella AC
J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
[TBL] [Abstract][Full Text] [Related]
8. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
[TBL] [Abstract][Full Text] [Related]
10. Fbxw7 controls angiogenesis by regulating endothelial Notch activity.
Izumi N; Helker C; Ehling M; Behrens A; Herzog W; Adams RH
PLoS One; 2012; 7(7):e41116. PubMed ID: 22848434
[TBL] [Abstract][Full Text] [Related]
11. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
Guo Z; Zhou Y; Evers BM; Wang Q
Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
[TBL] [Abstract][Full Text] [Related]
12. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
13. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
[TBL] [Abstract][Full Text] [Related]
14. Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis.
Yang Y; Gao X; Zhang M; Yan S; Sun C; Xiao F; Huang N; Yang X; Zhao K; Zhou H; Huang S; Xie B; Zhang N
J Natl Cancer Inst; 2018 Mar; 110(3):304-15. PubMed ID: 28903484
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
16. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
[TBL] [Abstract][Full Text] [Related]
17. Loss of CDC4/FBXW7 in gastric carcinoma.
Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
[TBL] [Abstract][Full Text] [Related]
18. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
[TBL] [Abstract][Full Text] [Related]
19. Aberrant regulation of FBW7 in cancer.
Wang L; Ye X; Liu Y; Wei W; Wang Z
Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581
[TBL] [Abstract][Full Text] [Related]
20. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
